John W. Davis

发表

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

P. Schellhammer, Y. Yasui, B. Adam, 2002, Cancer research.

Robotic surgery training with commercially available simulation systems in 2011: a current review and practice pattern survey from the society of urologic robotic surgeons.

John W. Davis, C. Lallas, John W Davis, 2012, Journal of endourology.

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

Andrew J. Vickers, James L. Mohler, Geoffrey A. Sonn, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Prostate cancer upgrading or downgrading of biopsy Gleason scores at radical prostatectomy: prediction of “regression to the mean” using routine clinical features with correlating biochemical relapse rates

P. Troncoso, John W. Davis, S. Matin, 2019, Asian journal of andrology.

Radical Retropubic Prostatectomy

P. Schellhammer, John W. Davis, 2003 .

Laparoscopic radical prostatectomy--an analysis of factors affecting operating time.

S. Loening, I. Tuerk, John W. Davis, 2003, Urology.

Lymphadenectomy with Robotic Cystectomy

John W. Davis, A. Kamat, 2013, Current Urology Reports.

Robot assisted extended pelvic lymphadenectomy at radical cystectomy: lymph node yield compared with second look open dissection.

C. Dinney, John W. Davis, M. Munsell, 2011, The Journal of urology.

Complications after robot-assisted radical cystectomy with urinary diversion: New approach same old foe

John W. Davis, F. Bianco, 2011 .

Unintended consequences of decreased PSA-based prostate cancer screening

T. Ahlering, J. Kaouk, R. Abaza, 2018, World Journal of Urology.

Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer

John W. Davis, J. Boughey, T. Hoskin, 2020, Annals of Surgical Oncology.

Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer.

R. Babaian, John W. Davis, Prof Vikas Kumar, 2008, The Journal of urology.

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

J. Eastham, R. Chou, S. Boorjian, 2022, The Journal of urology.

Robot-Assisted Radical Prostatectomy

John W. Davis, 2016 .

Recommendations on Use of Prostate-Specific Antigen for Prostate Cancer Screening—Reply

John W. Davis, Jeri Kim, 2012 .

Genitourinary Cancer Survivorship Management

D. Kuban, K. Hoffman, John W. Davis, 2015 .

Laparoscopic live donor right nephrectomy: a new technique with preservation of vascular length.

S. Loening, John W. Davis, M. Fabrizio, 2002, The Journal of urology.

Endorectal MRI for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy

D. Kuban, S. McGuire, Andrew K. Lee, 2014 .

Sural nerve graft during laparoscopic radical prostatectomy. Initial experience.

P. Schellhammer, S. Loening, John W. Davis, 2002, Urologic oncology.

Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System.

John W. Davis, S. Matin, C. Pettaway, 2016, Clinical genitourinary cancer.

Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy

John W. Davis, F. Petros, Roger Li, 2016, Investigative and clinical urology.

Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer☆

P. Brown, I. Thompson, H. Parnes, 2016, EBioMedicine.

A case‐mix‐adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons

P. Dasgupta, John W. Davis, 2013, BJU international.

Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup.

P. Schellhammer, John W. Davis, Seemit I Sheth, 2002, The Journal of urology.

Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design.

John W. Davis, Xuemei Wang, Q. Nguyen, 2019, European urology focus.

Tumors of the Penis

John W. Davis, C. Pettaway, R. Lance, 2012 .

The BJUI's clinical trials initiative

John W. Davis, G. MacLennan, G. Maclennan, 2017, BJU international.

Prostate cancer screening--time to abandon one-size-fits-all approach?

John W. Davis, Jeri Kim, 2011, JAMA.

Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes.

John W. Davis, C. Pettaway, L. Pisters, 2018, European urology.

Retracted: Many young men with prostate‐specific antigen (PSA) screen‐detected prostate cancers may be candidates for active surveillance

John W. Davis, E. Canby-Hagino, Jeri Kim, 2013, BJU international.

Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends

D. Kuban, S. McGuire, K. Hoffman, 2019, Cancer.

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions

J. Eastham, R. Chou, S. Boorjian, 2022, The Journal of urology.

Outcomes and risk factors in 1,609 carotid endarterectomies.

John W. Davis, J. Duncan, G. Reul, 2008, Texas Heart Institute journal.

Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy.

John W. Davis, C. Pettaway, L. Pisters, 2016, The Canadian journal of urology.

Surgical techniques to improve continence recovery after robot-assisted radical prostatectomy

John W. Davis, W. Ranasinghe, A. Urkmez, 2020, Translational andrology and urology.

Robotically assisted radical laparoscopic prostatectomy in a patient with ectopic ureteral insertion into the prostate

John W. Davis, M. Fabrizio, S. Hubosky, 2007, Journal of robotic surgery.

Live surgery: highly educational or harmful?

C. Abbou, John W. Davis, I. Gill, 2018, World Journal of Urology.

Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research

John W. Davis, S. McRae, C. Pettaway, 2018, Prostate Cancer and Prostatic Diseases.

Learning curve assessment of robot-assisted radical prostatectomy compared with open-surgery controls from the premier perspective database.

Raju Thomas, John W. Davis, U. Kreaden, 2014, Journal of endourology.

Robotic or open radical prostatectomy after previous open surgery in the pelvic region

John W. Davis, C. Pettaway, L. Pisters, 2015, Korean journal of urology.

Integrative analysis of the MD Anderson Prostate Cancer Patient-Derived Xenograft Series (MDA PCa PDX)

E. Vazquez, P. Troncoso, John W. Davis, 2022, bioRxiv.

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up

J. Eastham, R. Chou, S. Boorjian, 2022, The Journal of urology.

Positive margins after laparoscopic radical prostatectomy: a prospective study of 100 cases performed by 4 different surgeons.

S. Loening, I. Tuerk, John W. Davis, 2003, European urology.

Popliteal vein aneurysm presenting as a popliteal mass.

John W. Davis, J. Livesay, L. J. Herrera, 2006, Texas Heart Institute journal.

Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer

P. Schellhammer, John W. Davis, M. Fabrizio, 2011 .

Does the diagnosing urologist influence choice of initial active treatment versus observation in older men with favorable prostate cancer?

D. Kuban, Jing Jiang, Benjamin D. Smith, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of genomic markers to risk stratify men with prostate cancer

John W. Davis, 2015 .

Novel commercially available genomic tests for prostate cancer: a roadmap to understanding their clinical impact

John W. Davis, 2014, BJU international.

Radical Retropubic Prostatectomy

P. Schellhammer, John W. Davis, 2003 .

ASO Author Reflections: How Predictive Models Can Help Guide Axillary Surgery Decision Making After Neoadjuvant Chemotherapy

John W. Davis, J. Boughey, 2020, Annals of Surgical Oncology.

Cancer Surgery Scheduling During and After the COVID-19 First Wave

S. Swisher, J. Vauthey, John W. Davis, 2020, Annals of surgery.

Robot‐assisted extended pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP): a video‐based illustration of technique, results, and unmet patient selection needs

John W. Davis, J. Shah, M. Achim, 2011, BJU international.

Robot-Assisted Pelvic Lymphadenectomy

John W. Davis, K. Gaston, 2014 .

Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer

P. Schellhammer, John W. Davis, H. Beydoun, 2010, BJU international.

Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor.

John W. Davis, L. Pisters, S. Donat, 2002, Urology.

Resection of Metastatic Cancer in Castration-Resistant Patients

John W. Davis, J. Gregg, Chad A. Reichard, 2018 .

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.

P. Troncoso, John W. Davis, C. Logothetis, 2019, European urology.

Laparoscopic-assisted colpotomy for ovariectomy in the mare.

L. P. Tate, John W. Davis, C. Fogle, 2012, Veterinary surgery : VS.

Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.

C. Wood, P. Troncoso, R. Babaian, 2009, European urology.

The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, Colorectal, Lung, or Prostate Cancer: A Systematic Review and Meta-analysis

V. Laudone, M. Gonen, John W. Davis, 2022, Annals of surgery.

Re: Randomized Comparison of Techniques for Control of the Dorsal Venous Complex During Robot-assisted Laparoscopic Radical Prostatectomy.

John W. Davis, 2020, European urology.

Testicular and Penile Cancer

P. Schellhammer, John W. Davis, D. Lynch, 2007 .

Improving risk-stratification of localized prostate cancer in a prospective active surveillance cohort.

D. Kuban, John W. Davis, Seungtaek L. Choi, 2018 .

Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer

Jennifer B Dennison, S. Hanash, C. Creighton, 2020, Nature Communications.

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance

M. Cooperberg, E. Klein, John W. Davis, 2019, Prostate Cancer and Prostatic Diseases.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

P. Carroll, R. Stoyanova, A. Tewari, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer

S. Hanash, D. Kuban, P. Troncoso, 2018, BJU international.

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.

Daniel E Spratt, Todd M Morgan, Samir S Taneja, 2019, European urology.

Diet quality and Gleason grade progression among localised prostate cancer patients on active surveillance

C. Daniel, John W. Davis, Jeri Kim, 2019, British Journal of Cancer.

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance

B. Trock, E. Klein, John W. Davis, 2018, Prostate Cancer and Prostatic Diseases.

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.

J. Richie, M. Loda, P. Kantoff, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Urinary continence recovery after radical prostatectomy – anatomical/reconstructive and nerve‐sparing techniques to improve outcomes

John W. Davis, C. Pavlovich, B. Rocco, 2017, BJU international.

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

P. Friedl, P. Troncoso, John W. Davis, 2015, Oncotarget.

Genetic associations of T cell cancer immune response with tumor aggressiveness in localized prostate cancer patients and disease reclassification in an active surveillance cohort

J. Gu, Xifeng Wu, Y. Ye, 2018, Oncoimmunology.

The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.

V. Patel, John W. Davis, J. Rassweiler, 2018, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.

H. G. van der Poel, P. Dasgupta, A. Mottrie, 2021, Urologic oncology.

Salvage radical prostatectomy for recurrent prostate cancer: morbidity and functional outcomes from a large multicenter series of open versus robotic approaches.

H. G. van der Poel, P. Dasgupta, A. Mottrie, 2019, The Journal of urology.

Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase.

John W. Davis, S. Matin, J. Gregg, 2021, Urology.

Biochemical recurrence after radical prostatectomy: Current status of its use as a treatment endpoint and early management strategies

John W. Davis, S. Williams, Barrett Z. McCormick, 2019, Indian journal of urology : IJU : journal of the Urological Society of India.

Physician variation in management of low-risk prostate cancer: a population-based cohort study.

Robert J Volk, Yu Shen, Karen E Hoffman, 2014, JAMA internal medicine.

Patients’ Survival Expectations before Localized Prostate Cancer Treatment by Treatment Status

P. Schellhammer, John W. Davis, H. Beydoun, 2009, The Journal of the American Board of Family Medicine.

Mitochondrial DNA copy number in peripheral blood leukocytes is associated with biochemical recurrence in prostate cancer patients in African Americans.

J. Gu, John W. Davis, C. Logothetis, 2019, Carcinogenesis.

Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer

J. Gu, Xifeng Wu, John W. Davis, 2015, Oncotarget.

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

P. Carroll, Ruth Etzioni, W. Lowrance, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Increased body mass index is associated with operative difficulty during robot‐assisted radical prostatectomy

John W. Davis, C. Pettaway, J. Ward, 2021, BJUI compass.

Minimally invasive treatments for bladder cancer – from transurethral resection to laparoscopic radical cystectomy

S. Loening, I. Tuerk, John W. Davis, 2005 .

Initial experience of teaching robot‐assisted radical prostatectomy to surgeons‐in‐training: can training be evaluated and standardized?

John W. Davis, S. Matin, M. Munsell, 2010, BJU international.

Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.

P. Schellhammer, John W. Davis, M. Fabrizio, 2006, Journal of endourology.

Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions.

John W. Davis, H. Demirel, 2018, Turkish journal of urology.

Long-term follow-up of intravesical bacillus Calmette-Guérin treatment for superficial transitional-cell carcinoma of the bladder involving the prostatic urethra.

P. Schellhammer, John W. Davis, Jonathan H. Taylor, 2007, Clinical genitourinary cancer.

Prostate Cancer Early Detection, Version 2.2015

P. Carroll, Ruth Etzioni, W. Lowrance, 2015 .

Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer

P. Troncoso, John W. Davis, Xuemei Wang, 2018, Prostate Cancer and Prostatic Diseases.

Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8‐10) prostate cancer treated primarily by radical prostatectomy

C. Reddy, E. Klein, John W. Davis, 2021, Cancer.

Cytoreduction and androgen signaling modulation by abiraterone acetate (AA) plus leuprolide acetate (LHRHa) versus LHRHa in localized high-risk prostate cancer (PCa): Preliminary results of a randomized preoperative study.

P. Troncoso, John W. Davis, C. Logothetis, 2012 .

Port-site hernias occurring after the use of bladeless radially expanding trocars.

John W. Davis, S. Matin, A. Kamat, 2010, Urology.

Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients

J. Gu, John W. Davis, C. Logothetis, 2020, EBioMedicine.

Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial.

N. Robert, John W. Davis, K. Kern, 2011, Clinical breast cancer.

Locoregional Management of the Axilla in Mastectomy Patients with One or Two Positive Sentinel Nodes: The Role of Intraoperative Pathology.

J. Cheville, John W. Davis, J. Boughey, 2021, Clinical breast cancer.

Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study

P. Schellhammer, John W. Davis, H. Beydoun, 2011, Quality of Life Research.

Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance.

J. Gu, Xifeng Wu, Y. Ye, 2016, Carcinogenesis.

Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable‐risk prostate cancer undergoing active surveillance

D. Kuban, Andrew K. Lee, K. Hoffman, 2016, BJU international.

Salvage topical therapy for upper tract urothelial carcinoma

C. Wood, C. Dinney, John W. Davis, 2018, World Journal of Urology.

Optimizing the diagnosis and management of ductal prostate cancer

B. Broom, T. Bathala, John W. Davis, 2021, Nature Reviews Urology.

Comparing confirmatory biopsy outcomes between MRI‐targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance

H. Kang, John W. Davis, Haesun Choi, 2020, BJU international.

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now

H. Woo, B. Hadaschik, John W. Davis, 2020, Prostate Cancer and Prostatic Diseases.

Is there a role for serum human tissue kallikrein in detection of prostate cancer?

R. Babaian, John W. Davis, A. Ochiai, 2007, Urology.

Adult Urology Is There a Role for Serum Human Tissue Kallikrein in Detection of Prostate Cancer

R. Babaian, John W. Davis, A. Ochiai, 2007 .

“TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now

B. Hadaschik, John W. Davis, C. Moore, 2020, Prostate Cancer and Prostatic Diseases.

Focal therapy for localized prostate cancer: is there a “middle ground” between active surveillance and definitive treatment?

John W. Davis, M. Altok, C. Demirel, 2018, Asian journal of andrology.

Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3Tesla Multiparametric Prostate Magnetic Resonance Imaging.

E. Messing, A. Oto, John W. Davis, 2019, European urology oncology.

Impact of MRI/US fusion‐guided prostate biopsy on biopsy‐naïve patients: A single urologist’s experience

H. Kang, John W. Davis, Haesun Choi, 2021, BJUI compass.

Circulating tumor cell assays for the prognosis of prostate and colon cancers.

John W. Davis, John W Davis, 2009, Expert opinion on medical diagnostics.

Laparoscopic dismembered pyeloplasty--the method of choice in the presence of an enlarged renal pelvis and crossing vessels.

S. Loening, John W. Davis, M. Fabrizio, 2002, European urology.

Modified running vesicourethral anastomosis after robotically assisted laparoscopic radical prostatectomy: use of solitary Lapra-Ty to secure posterior approximation.

John W. Davis, M. Fabrizio, D. Lynch, 2005, Urology.

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Steven J Frank, D. Kuban, Andrew K. Lee, 2007, The Journal of urology.

Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort

C. Daniel, John W. Davis, Jeri Kim, 2021, Cancer.

Overexpression of α-defensin is associated with bladder cancer invasiveness

A. Vlahou, P. Schellhammer, John W. Davis, 2006 .

Quality of Life: Impact of Prostate Cancer and its Treatment

P. Schellhammer, John W. Davis, 2003 .

Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer.

J. Gu, Xifeng Wu, John W. Davis, 2017, Oncology letters.

Overexpression of alpha-defensin is associated with bladder cancer invasiveness.

A. Vlahou, P. Schellhammer, John W. Davis, 2006, Urologic oncology.

Effectiveness of postgraduate training for learning extraperitoneal access for robot-assisted radical prostatectomy.

John W. Davis, S. Matin, M. Munsell, 2011, Journal of endourology.

Robotic or Open Radical Prostatectomy in Men with Previous Transurethral Resection of Prostate.

John W. Davis, L. Pisters, S. N. Gorgel, 2017, Urologia Journal.

Extended Pelvic Lymph Node Dissection in Bladder Cancer.

John W. Davis, F. Petros, Roger Li, 2018, Journal of endourology.

Determining Clinically-Based Factors Associated with Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort.

D. Kuban, P. Troncoso, R. Babaian, 2019, Urology.

Sequencing robot‐assisted extended pelvic lymph node dissection prior to radical prostatectomy: a step‐by‐step guide to exposure and efficiency

John W. Davis, Y. Bozkurt, M. Achim, 2016, BJU international.

Minimally Invasive Access to the Prostate: The Concept of Surgical Space Creation

John W. Davis, 2016 .

Does time from diagnosis to treatment of high‐ or very‐high‐risk prostate cancer affect outcome?

E. Klein, John W. Davis, J. Tosoian, 2019, BJU international.

Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort

D. Kuban, S. McGuire, K. Hoffman, 2018, BJU international.

Robot-assisted radical cystectomy: an expert panel review of the current status and future direction.

D. Ornstein, K. Guru, John W. Davis, 2010, Urologic oncology.

Patterns of metastases of prostatic ductal adenocarcinoma

T. Bathala, P. Troncoso, John W. Davis, 2020, Cancer.

Outcomes of very high‐risk prostate cancer after radical prostatectomy: Validation study from 3 centers

Misop Han, E. Klein, John W. Davis, 2018, Cancer.

An evaluation of bicalutamide in the treatment of prostate cancer.

P. Schellhammer, John W. Davis, 2004, Clinical prostate cancer.

Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate

M. Cooperberg, P. Carroll, R. Mehra, 2020 .

The Association of Peri-Prostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance.

T. Bathala, C. Daniel, John W. Davis, 2020, The Journal of urology.

Correlation of histomorphologic findings and partial neurovascular bundle preservation during laparoscopic and robotic radical prostatectomy

P. Troncoso, John W. Davis, S. Matin, 2011, Journal of Robotic Surgery.

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.

E. Klein, John W. Davis, M. Allaf, 2020, The Journal of urology.

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy.

R. Mehra, S. Freedland, P. Troncoso, 2017, European urology.

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.

B. Trock, R. Stoyanova, M. Arañes, 2017, European urology.

Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis.

J. Pow-Sang, V. Patel, John W. Davis, 2017, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes

John W. Davis, Haesun Choi, A. Venkatesan, 2021, World Journal of Urology.

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.

P. Troncoso, R. Babaian, John W. Davis, 2008, The Journal of urology.

Advances in Prostate Cancer Diagnosis: Triggers for Prostate Biopsy

John W. Davis, C. Mmeje, 2016 .

The International Prostate Forum introduction and history

R. Babaian, John W. Davis, T. Miki, 2015, Asian journal of andrology.

Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.

P. Carroll, Ruth Etzioni, W. Lowrance, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Prostate cancer early detection version 1

P. Carroll, Ruth Etzioni, W. Lowrance, 2014 .

Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.

C. Wood, C. Dinney, John W. Davis, 2017, Journal of endourology.

Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans.

John W. Davis, S. Matin, L. Elting, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer.

P. Schellhammer, John W. Davis, M. Fabrizio, 2005, Journal of endourology.

Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic.

D. Kuban, Andrew K. Lee, K. Hoffman, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

The implications of ageing and life expectancy in prostate cancer treatment

K. Hoffman, John W. Davis, R. Volk, 2016, Nature Reviews Urology.

Performance and Clinical Utility of Models Predicting Eradication of Nodal Disease in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy by Tumor Biology

John W. Davis, J. Boughey, A. Caudle, 2020, Annals of Surgical Oncology.

Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy

John W. Davis, J. Boughey, E. Habermann, 2021, Annals of Surgical Oncology.

Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.

D. Kuban, S. McGuire, K. Hoffman, 2018, International journal of radiation oncology, biology, physics.

Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.

D. Kuban, S. McGuire, Andrew K. Lee, 2013, Brachytherapy.

Biological heterogeneity in localized high-risk prostate cancer (LHRPC) from a study of neoadjuvant abiraterone acetate plus leuprolide acetate (LHRHa) versus LHRHa.

P. Troncoso, John W. Davis, C. Logothetis, 2015 .

TRENDS IN THE CARE OF RADICAL PROSTATECTOMY IN THE UNITED STATES FROM 2003 TO 2006

John W. Davis, Y. Shih, 2011, BJU international.

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance

M. Cooperberg, P. Carroll, E. Klein, 2019, Prostate Cancer and Prostatic Diseases.

Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer.

P. Schellhammer, John W. Davis, M. Fabrizio, 2010, The Journal of urology.

Editorial comment for Xu et al.

John W. Davis, 2015, Journal of endourology.

Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research

John W. Davis, S. McRae, C. Pettaway, 2018, Prostate Cancer and Prostatic Diseases.

Salvaging failed radiation therapy: does the tumour location permit a less toxic approach?

John W. Davis, S. Choi, 2013, BJU International.

Advances in Brief Quantitation of Serum Prostate-specific Membrane Antigen by a Novel Protein Biochip Immunoassay Discriminates Benign from Malignant Prostate Disease 1

P. Schellhammer, E. Dalmasso, B. Adam, 2001 .

A decade of robot-assisted radical prostatectomy training: Time-based metrics and qualitative grading for fellows and residents.

John W. Davis, S. Matin, C. Pettaway, 2018, Urologic oncology.

Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.

T. Bathala, P. Troncoso, John W. Davis, 2020, European urology.

Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.

John W. Davis, R. Karnes, E. Davicioni, 2019, European urology oncology.

Biomarker classification, validation, and what to look for in 2017 and beyond

John W. Davis, 2017, BJU international.

NICE guidelines on prostate cancer 2019

P. Dasgupta, John W. Davis, S. Hughes, 2019, BJU international.

Coffee, Caffeine Metabolism Genotype and Disease Progression in Patients with Localized Prostate Cancer Managed with Active Surveillance

C. Daniel, Y. Ye, John W. Davis, 2019, The Journal of urology.

Pelvic Lymph Node Dissection: Robotic Surgery Efficiency and Space-Creation Techniques to Achieve an Extended Template

John W. Davis, 2016 .

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

P. Friedl, P. Troncoso, John W. Davis, 2015 .

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

P. Friedl, P. Troncoso, John W. Davis, 2015 .

NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.

P. Carroll, Ruth Etzioni, W. Lowrance, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Value Added of Preoperative Contrast‐Enhanced Digital Mammography in Patients With Invasive Lobular Carcinoma of the Breast

John W. Davis, B. Pockaj, T. Ocal, 2018, Clinical breast cancer.

Do you need further assistance in diagnosing and risk stratifying prostate cancer?

John W. Davis, 2019, BJU International.

Surgeon’s Notebook: Beyond the Learning Curve: The Original Handouts from the American Urological Association Postgraduate Courses 2013–2015

C. Cheng, John W. Davis, D. Murphy, 2016 .

Focal therapy for localized prostate cancer: is there a “middle ground” between active surveillance and definitive treatment?

John W. Davis, M. Altok, C. Demirel, 2018, Asian journal of andrology.

Comparative Effectiveness Research/Health Technology Assessment Comparative Effectiveness, Cost, and Utilization of Radical Prostatectomy among Young Men within Managed Care Insurance Plans

John W. Davis, S. Matin, L. Elting, 2012 .

Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.

P. Carroll, Ruth Etzioni, W. Lowrance, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

The Simple Bladder Neck

John W. Davis, 2016 .

CCP score and risk stratification for prostate cancer patients at biopsy.

P. Scardino, E. Crawford, John W. Davis, 2014 .

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy.

R. Mehra, S. Freedland, P. Troncoso, 2017, European urology.